Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply

Rheumatology (Oxford). 2018 Nov 1;57(11):2060-2061. doi: 10.1093/rheumatology/key269.

Authors

Monica S M Persson^{1

2}, Aliya Sarmanova¹, Michael Doherty^{1

2}, Weiya Zhang^{1

2}

Affiliations

¹ Academic Rheumatology, University of Nottingham, Nottingham, UK.
² Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, UK.

PMID: 30204904
DOI: 10.1093/rheumatology/key269

No abstract available

Publication types

Comment

MeSH terms

Antirheumatic Agents*
Arthritis, Rheumatoid*
Biological Products*
Humans
Osteoarthritis*
Randomized Controlled Trials as Topic

Substances

Antirheumatic Agents
Biological Products